 WAYNE, Pa., March 09, 2021 GLOBE NEWSWIRE -- Teleflex Incorporated NYSE: TFX today announced that, globally, 250,000 patients have been treated with the UroLift System, a proven, minimally invasive approach to treating benign prostatic hyperplasia BPH. 